EUVIMEDEUVIMED entdecken
Klinische Studie (Phase II)ÄquivalenzstudieMultizentrische StudieOpen Access

Intravenous Rehydration for Severe Acute Malnutrition with Gastroenteritis

Kathryn Maitland iD, San Maurice Ouattara iD, Hadiza Sainna, Abdullahi Chara, Oluwakemi F Ogundipe, Temmy Sunyoto, M Hamaluba, Peter Olupot-Olupot, Florence Alaroker, Roisin Connon, Amadou Saidou Maguina, William Okiror und 12 weitere

New England Journal of Medicine · 2025

DOI: 10.1056/nejmoa2505752 ↗

Kurz gefasst

Klinische Studie (Phase II) in der Zeitschrift New England Journal of Medicine, 2025. Verfasst von Kathryn Maitland und 23 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Global Health and Innovation, Department of Surgery and Cancer, Imperial College London, London. Hauptthemen laut MEDLINE: Dehydration, Fluid Therapy, Gastroenteritis, Severe Acute Malnutrition. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Wellcome Trust, Medical Research Council, Medical Research Council Canada.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: International recommendations advise against the use of intravenous rehydration therapy in children with severe acute malnutrition because of the concern about fluid overload, but evidence to support this concern is lacking. Given the high mortality associated with the current recommendations, the adoption of intravenous rehydration strategies might improve outcomes. METHODS: We conducted a factorial, open-label superiority trial in four countries in Africa. Children 6 months to 12 years of age with severe acute malnutrition with gastroenteritis and dehydration underwent randomization in a 2:1:1 ratio to one of three rehydration strategies: oral rehydration, plus intravenous boluses for shock; a rapid intravenous strategy that consisted of lactated Ringer's solution (100 ml per kilogram of body weight) administered over a period of 3 to 6 hours, with boluses for shock; or a slow intravenous strategy that consisted of the same solution administered over a period of 8 hours, with no boluses. The primary end point was death at 96 hours. RESULTS: A total of 272 children underwent randomization; 138 were assigned to the oral strategy, 67 to the rapid intravenous strategy, and 67 to the slow intravenous strategy. Participants were followed for 28 days. A nasogastric tube was used for oral rehydration in 126 of 135 participants (93%) in the oral group and in 82 of 126 (65%) in the intravenous groups. Intravenous boluses were administered at admission in 12 participants (9%) in the oral group, 7 (10%) in the rapid intravenous group, and none in the slow intravenous group. At 96 hours, 11 participants (8%) in the oral group and 9 (7%) in the intravenous groups (5 in the rapid group and 4 in the slow group) had died (risk ratio, 1.02; 95% confidence interval [CI], 0.41 to 2.52; P = 0.69). At 28 days, 17 participants (12%) in the oral group and 14 (10%) in the intravenous groups had died (hazard ratio, 0.85; 95% CI, 0.41 to 1.78). Serious adverse events occurred in 32 participants (23%) in the oral group, 14 (21%) in the rapid intravenous group, and 10 (15%) in the slow intravenous group. No evidence of pulmonary edema, heart failure, or fluid overload was noted. CONCLUSIONS: Among children with severe acute malnutrition and gastroenteritis, no evidence of a difference in mortality at 96 hours was noted between oral and intravenous rehydration strategies. (Funded by the Joint Global Health Trials scheme and others; GASTROSAM Current Controlled Trials number, ISRCTN76149273.).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DehydrationFluid TherapyGastroenteritisSevere Acute MalnutritionChildChild, PreschoolFemaleHumansInfantMaleAdministration, OralInfusions, IntravenousKaplan-Meier EstimateRehydration SolutionsRinger's LactateShockAfricaTime FactorsFollow-Up StudiesTreatment Outcome

Substanzen

Rehydration SolutionsRinger's Lactate

Autor:innen und Institutionen

  • Institute of Global Health and Innovation, Department of Surgery and Cancer, Imperial College London, London.
  • Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi, Kenya.
  • Imperial College London, London.
  • Epicentre, Magaria, Niger.
  • Médecins Sans Frontières, Maiduguri, Nigeria.
  • Médecins Sans Frontières, Brussels.

ORCID-Profile: Kathryn Maitland, San Maurice Ouattara, Matthew E Coldiron

Förderung

  • Wellcome Trust
  • Medical Research Council
  • Medical Research Council Canada

Zitieren

APA

Maitland, K., Ouattara, S. M., Sainna, H., Chara, A., Ogundipe, O. F., Sunyoto, T., Hamaluba, M., Olupot-Olupot, P., Alaroker, F., Connon, R., Saidou Maguina, A., Okiror, W., Amorut, D., Mwajombo, E., Oguda, E., Mogaka, C., Langendorf, C., Dewez, J. E., Ciglenecki, I., …, & GASTROSAM Trial Group (2025). Intravenous Rehydration for Severe Acute Malnutrition with Gastroenteritis. New England Journal of Medicine. https://doi.org/10.1056/nejmoa2505752

Vancouver

Maitland K, Ouattara SM, Sainna H, Chara A, Ogundipe OF, Sunyoto T, et al. Intravenous Rehydration for Severe Acute Malnutrition with Gastroenteritis. New England Journal of Medicine. 2025. doi:10.1056/nejmoa2505752

BibTeX
@article{Maitland2025,
  author = {Maitland, Kathryn and Ouattara, San Maurice and Sainna, Hadiza and Chara, Abdullahi and Ogundipe, Oluwakemi F and Sunyoto, Temmy and Hamaluba, M and Olupot-Olupot, Peter and Alaroker, Florence and Connon, Roisin and Saidou Maguina, Amadou and Okiror, William and Amorut, Denis and Mwajombo, Eric and Oguda, Emmanuel and Mogaka, Christabel and Langendorf, Céline and Dewez, Juan Emmanuel and Ciglenecki, Iza and Gibb, Diana M and Coldiron, Matthew E and Petrucci, Roberta and George, Elizabeth C and GASTROSAM Trial Group, GASTROSAM Trial Group},
  title = {Intravenous Rehydration for Severe Acute Malnutrition with Gastroenteritis},
  journal = {New England Journal of Medicine},
  year = {2025},
  doi = {10.1056/nejmoa2505752}
}
Kostenlos starten →